Module 4: Study Conduct

Study Conduct emphasizes components of study conduct and post-trial commitments to address barriers in participation and trust.

Target Audience

This activity is intended for leadership, investigators, practicing providers, clinical trialists, clinical trial staff, nurse practictioners, nurses, research nurse specialists, physician assistants, clinical research coordinators, other frontline staff, regulatory and IRB committee members, and others who design, conduct, report or are responsible for clinical research.

Learning Objectives

Upon completion of this activity, participants will be able to:

  • Identify strategies for retention and appropriateness of payment for participation in clinical trials
  • Address inclusion of people with disabilities in clinical trials
  • Discuss end-of-trial and post-trial responsibilities to participants

Additional Information

Provided by: 

PLEASE NOTE: For questions or assistance with any special needs regarding the training course, please contact the MRCT Center at:  MRCT@bwh.harvard.edu

YOU MAY ALSO BE INTERESTED IN Interpretation and Application of ICH E6(R2)
Welcome to Version 1.0 of Interpretation and Application of ICH E6(R2) – an online course developed by the MRCT Center with a multi-stakeholder international team of experts.

Course summary
Course opens: 
07/15/2022
Course expires: 
07/15/2023
Cost:
$0.00

MANY THANKS TO THE FOLLOWING PEOPLE FOR ACTING AS DISCUSSANTS DURING THIS TRAINING SERIES:

Dr. Christopher S. Lathan, Chief Clinical Access and Equity Officer, Dana-Farber Cancer Institute; Christopher and Constance Hadley Family Chair, Dana-Farber Cancer Institute; Associate Medical Director, Dana-Farber Cancer Institute Network; Associate Professor of Medicine, Harvard Medical School

Dr. Sapna S. McManus; Head of Patient Inclusion & Health Equity and Chief Diversity Officer, Genentech

This activity is not for credit.

Price

Cost:
$0.00
Please login or register to take this course.